Fluid at Work Study

Sponsor
King's College London (Other)
Overall Status
Recruiting
CT.gov ID
NCT05260840
Collaborator
British Dietetic Association (Other)
81
1
8.1
10

Study Details

Study Description

Brief Summary

The aim of the Fluid at Work Study is to develop and evaluate a fluid intake measurement tool for use in the UK working population.

From the results of a systematic review and a round table discussion a novel fluid measurement tool has been developed - the Workplace Beverage Intake Questionnaire (WBIQ)

The observational evaluation study will measure the relative validity and reliability of WBIQ for assessing fluid intake in a workplace population.

Condition or Disease Intervention/Treatment Phase
  • Other: Evaluation study - provision of an online questionnaire

Detailed Description

The aim of the Fluid at Work Study is to develop and evaluate a fluid intake measurement tool for use in the UK working population.

From the results of a systematic review and a round table discussion a novel fluid measurement tool has been developed - the Workplace Beverage Intake Questionnaire (WBIQ)

WBIQ will be used to conduct a preliminary investigation of relative validity and reliability. Relative validity of the tool will be tested, rather than 'absolute validity', as there is no 'gold' standard measure for exact fluid intake in free living population groups.

Individuals responding to local advertisements will complete an initial telephone or email questionnaire, and then eligible respondents will be asked to attend King's College London for a screening visit where they will be asked questions to confirm their inclusion criteria. Inclusion criteria: full-time disked based/ office workers. Following confirmation of eligibility and written consent participants will be asked to attend two study visits 7-days apart and complete three on-line fluid intake surveys.

Study Design

Study Type:
Observational
Anticipated Enrollment :
81 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Establishing and Evaluating a Beverage Intake Measurement Tool for the UK Workplace: The Fluid at Work Study
Actual Study Start Date :
Feb 28, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Relative validity of fluid intake measurement [7 days]

    Measured against 24-hr urine output, specific gravity and 7 day reported fluid intake

  2. Reliability of fluid intake measurement (l/day) [2 months]

    Comparison of WBIQ responses at 3 time points

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Full-time employee working in a desk-based role

  • No history of heart attack, stroke, angina, thrombosis, liver or kidney diseases, diabetes, chronic gastrointestinal disorder, or cancer

  • Able to remain within the UK during the 8-10-week period of testing

  • No history of excess alcohol intake or substance abuse

  • Agree to not drink alcohol for the 7-day period of dietary data collection

  • Not already participating in a clinical trial

  • Not currently taking medication that is likely to alter kidney function or fluid balance

  • Able to understand the information sheet and willing to comply with study protocol

  • Able to give informed written consent

Exclusion Criteria:
  • Pregnant or breast feeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Life Course Sciences London United Kingdom SE1 9NH

Sponsors and Collaborators

  • King's College London
  • British Dietetic Association

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT05260840
Other Study ID Numbers:
  • GET2019
First Posted:
Mar 2, 2022
Last Update Posted:
Mar 29, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by King's College London

Study Results

No Results Posted as of Mar 29, 2022